Cost-Effectiveness of Patient Navigation to Increase Adherence With Screening Colonoscopy Among Minority Individuals

被引:34
|
作者
Ladabaum, Uri [1 ,2 ]
Mannalithara, Ajitha [1 ,2 ]
Jandorf, Lina [3 ]
Itzkowitz, Steven H. [4 ]
机构
[1] Stanford Univ, Sch Med, Div Gastroenterol Hepatol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[3] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Div Canc Prevent & Control, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, Dept Med, New York, NY 10029 USA
关键词
colorectal cancer; colorectal neoplasia; screening; adherence; disparities; FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; SERVICES TASK-FORCE; COLORECTAL-CANCER; CLINICAL-TRIAL; STRATEGIES; RECOMMENDATIONS; SIGMOIDOSCOPY; SURVEILLANCE; POLYPECTOMY;
D O I
10.1002/cncr.29162
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDColorectal cancer (CRC) screening is underused by minority populations, and patient navigation increases adherence with screening colonoscopy. In this study, the authors estimated the cost-effectiveness of navigation for screening colonoscopy from the perspective of a payer seeking to improve population health. METHODSA validated model of CRC screening was informed with inputs from navigation studies in New York City (population: 43% African American, 49% Hispanic, 4% white, 4% other; base-case screening: 40% without navigation, 65% with navigation; navigation costs: $29 per colonoscopy completer, $21 per noncompleter, $3 per non-navigated individual). Two analyses compared: 1) navigation versus no navigation for 1-time screening colonoscopy in unscreened individuals aged 50 years; and 2) programs of colonoscopy with versus without navigation versus fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT) for individuals ages 50 to 80 years. RESULTSIn the base case: 1) 1-time navigation gained quality-adjusted life-years (QALYs) and decreased costs; 2) longitudinal navigation cost $9800 per QALY gained versus no navigation, and, assuming comparable uptake rates, it cost $118,700 per QALY gained versus FOBT but was less effective and more costly than FIT. The results were most dependent on screening participation rates and navigation costs: 1) assuming a 5% increase in screening uptake with navigation, and a navigation cost of $150 per completer, 1-time navigation cost $26,400 per QALY gained; and 2) longitudinal navigation with 75% colonoscopy uptake cost <$25,000 per QALY gained versus FIT when FIT uptake was <50%. Probabilistic sensitivity analyses did not alter the conclusions. CONCLUSIONSNavigation for screening colonoscopy appears to be cost-effective, and 1-time navigation may be cost-saving. In emerging health care models that reward outcomes, payers should consider covering the costs of navigation for screening colonoscopy. Cancer 2015;121:1088-1097. (c) 2014 American Cancer Society. Navigation increases uptake of screening colonoscopy among minority individuals. The results from this study suggest that navigation in a longitudinal screening colonoscopy program is likely to be cost effective, and that 1-time navigation in previously unscreened indivaduals may be cost saving.
引用
收藏
页码:1088 / 1097
页数:10
相关论文
共 50 条
  • [41] Culturally Targeted Patient Navigation for Increasing African Americans' Adherence to Screening Colonoscopy: A Randomized Clinical Trial
    Jandorf, Lina
    Braschi, Caitlyn
    Ernstoff, Elizabeth
    Wong, Carrie R.
    Thelemaque, Linda
    Winkel, Gary
    Thompson, Hayley S.
    Redd, William H.
    Itzkowitz, Steven H.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1577 - 1587
  • [42] A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities
    Christie, Jennifer
    Itzkowitz, Steven
    Lihau-Nkanza, Irene
    Castillo, Anabella
    Redd, William
    Jandorf, Lina
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (03) : 278 - 284
  • [43] Cost-effectiveness of Artificial Intelligence-Aided Colonoscopy for Adenoma Detection in Colon Cancer Screening
    Barkun, Alan N.
    von Renteln, Daniel
    Sadri, Hamid
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2023, 6 (03) : 97 - 105
  • [44] Estimating cost-effectiveness of screening for colorectal cancer in Vietnam
    Tran, Binh Thang
    Choi, Kui Son
    Sohn, Dae Kyung
    Kim, Sun-Young
    Suh, Jae Kyung
    Tran, Thanh Huong
    Nguyen, Thi Thanh Binh
    Oh, Jin-Kyoung
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (06) : 1211 - 1220
  • [45] Cost-effectiveness of screening for bowel cancer
    Bolin, Terry D.
    Korman, Melvyn G.
    Nicholson, Fiona
    Pezzullo, Lynne
    Engelman, Jeffrey
    Collings, Katherine
    Creelman, David Gilchrist
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (01) : 11 - 13
  • [46] Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70 years of age
    Goverde, Anne
    Spaander, Manon C. W.
    van Doom, Helena C.
    Dubbink, Hendrikus J.
    van den Ouweland, Ans M. W.
    Tops, Carli M.
    Kooi, Sjarlot G.
    de Waard, Judith
    Hoedemaeker, Robert F.
    Bruno, Marco J.
    Hofstra, Robert M. W.
    de Bekker-Grob, Esther W.
    Dinjens, Winand N. M.
    Steyerberg, Ewout W.
    Wagner, Anja
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 453 - 459
  • [47] Cost-effectiveness of Colorectal Cancer Screening
    Lansdorp-Vogelaar, Iris
    Knudsen, Amy B.
    Brenner, Hermann
    EPIDEMIOLOGIC REVIEWS, 2011, 33 (01) : 88 - 100
  • [48] Cost-effectiveness of family history-based colorectal cancer screening in Australia
    Ouakrim, Driss A.
    Boussioutas, Alex
    Lockett, Trevor
    Hopper, John L.
    Jenkins, Mark A.
    BMC CANCER, 2014, 14
  • [49] Costs and Cost-Effectiveness of Targeted, Personalized Risk Information to Increase Appropriate Screening by First-Degree Relatives of People With Colorectal Cancer
    Reeves, Penny
    Doran, Christopher
    Carey, Mariko
    Cameron, Emilie
    Sanson-Fisher, Robert
    Macrae, Finlay
    Hill, David
    HEALTH EDUCATION & BEHAVIOR, 2019, 46 (05) : 798 - 808
  • [50] Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States
    Boklage, Susan H.
    Mangel, Allen W.
    Ramamohan, Varun
    Mladsi, Deirdre
    Wang, Tao
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 45 - 55